Literature DB >> 16368829

Nonsteroidal antiinflammatory drugs suppress pain-related behaviors, but not referred hyperalgesia of visceral pain in mice.

Jin-Woo Shin1, Kyu-Sam Hwang, Yoo-Kyung Kim, Jeong-Gill Leem, Cheong Lee.   

Abstract

Visceral pain is characterized by spontaneous pain and referred hyperalgesia. After inducing visceral pain in mice using intracolonic mustard oil administration, we examined the effects of various nonsteroidal antiinflammatory drugs (NSAIDs) on pain-related behavior and on Evans blue dye extravasation. Animals were given one of the following: saline, ethanol, dimethylsulfoxide (DMSO), morphine, ketoprofen, ketorolac, or DFU (a cyclooxygenase-2 inhibitor). After drug treatment, mice underwent intracolonic administration of 50 microL 1.5% mustard oil. Spontaneous pain-related responses were assessed for the next 20 min. The frequency of withdrawal responses to the application of von Frey hairs to the abdomen, foot, and tail was determined. After completion of the behavioral tests, Evans blue was injected into the animals via the tail vein. Two hours later, the colon was removed postmortem and Evans blue content was measured. Spontaneous pain behaviors were significantly less in animals administered 3 and 10 mg/kg morphine, 50 mg/kg ketorolac, 100 mg/kg ketoprofen, and 20 mg/kg DFU (P < 0.05). Response frequencies to the application of von Frey hairs were lower in mice administered 3 and 10 mg/kg morphine (P < 0.05) but were not affected by ketorolac, ketoprofen, or DFU treatment. Colonic Evans blue content was smaller in mice given 100 mg/kg ketoprofen and 20 mg/kg DFU (P < 0.05). We concluded that NSAIDs reduced pain behavior and inflammation but had little effect on referred hyperalgesia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16368829     DOI: 10.1213/01.ane.0000184828.39754.a3

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  6 in total

1.  Evaluation of the controlled release ability from the poly(2-hydroxyethyl methacrylate-co-3,9-divinyl-2,4,8,10-tetraoxaspiro[5.5]-undecane) polymer network synthesized in the presence of β-cyclodextrin.

Authors:  Loredana E Nita; Aurica P Chiriac; Manuela T Nistor; Liliana Tartau
Journal:  J Mater Sci Mater Med       Date:  2012-03-14       Impact factor: 3.896

2.  Ketoprofen-liposomes formulation for clinical therapy.

Authors:  Liliana Tarţău; Ana Cazacu; V Melnig
Journal:  J Mater Sci Mater Med       Date:  2012-07-04       Impact factor: 3.896

3.  Cyclooxygenases, microsomal prostaglandin E synthase-1, and cardiovascular function.

Authors:  Yan Cheng; Miao Wang; Ying Yu; John Lawson; Colin D Funk; Garret A Fitzgerald
Journal:  J Clin Invest       Date:  2006-04-13       Impact factor: 14.808

4.  Urinary bladder function and somatic sensitivity in vasoactive intestinal polypeptide (VIP)-/- mice.

Authors:  Simon Studeny; Bopaiah P Cheppudira; Susan Meyers; Elena M Balestreire; Gerard Apodaca; Lori A Birder; Karen M Braas; James A Waschek; Victor May; Margaret A Vizzard
Journal:  J Mol Neurosci       Date:  2008-06-17       Impact factor: 3.444

Review 5.  Preclinical Assessment of Inflammatory Pain.

Authors:  Milind M Muley; Eugene Krustev; Jason J McDougall
Journal:  CNS Neurosci Ther       Date:  2015-12-10       Impact factor: 5.243

6.  Effects of Tetrodotoxin in Mouse Models of Visceral Pain.

Authors:  Rafael González-Cano; Miguel Ángel Tejada; Antonia Artacho-Cordón; Francisco Rafael Nieto; José Manuel Entrena; John N Wood; Cruz Miguel Cendán
Journal:  Mar Drugs       Date:  2017-06-21       Impact factor: 5.118

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.